Eagle Pharmaceuticals (NASDAQ: EGRX) announced that the United States Patent and Trademark Office (“USPTO”) has granted U.S. Patent No. 9,034,908 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE